Viewing Study NCT02245828


Ignite Creation Date: 2025-12-26 @ 11:13 AM
Ignite Modification Date: 2026-03-03 @ 10:05 AM
Study NCT ID: NCT02245828
Status: COMPLETED
Last Update Posted: 2016-03-22
First Post: 2014-08-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of QCC374
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Subjects View
Keywords:

Keywords

Keyword Brief Keyword Text View
None healthy subjects, inhaled View